CureAge Therapeutics
Biotechnology Research
5 employees
- Employees
- 5
- Contacts
- 2
- Emails
- 2
CureAge Therapeutics Overview
- Website
- www.cureagetx.com
- Industry
- Biotechnology Research
- Employees
- 5
- Founded
- 2024
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
Keywords
About CureAge Therapeutics
We develop genetic medicines to improve the future of people living with peripheral nerve diseases, starting with Neurofibromatosis type 1 (NF1). Founded by the Children’s Tumor Foundation and Deep Science Ventures, CureAge brings together patients, scientists, and entrepreneurs to build the first curative therapy for NF1 and other Schwann cell-related disorders.
CureAge Therapeutics Contact Details
- People in AeroLeads
- 4
- With contact data
- 2
- Email contacts
- 2
- 50.0% coverage
CureAge Therapeutics Org Chart
Sample employees and titles| Name | Title | Location | Contact |
|---|---|---|---|
| Liron Elkouby | Co-founder and CTO at Cureage | Modiin-maccabim-reut, Center District, Israel |
Email
|
| Montse Montaner | Sustainability, Healthcare, Regulatory | Zurich, Switzerland |
Email
|
| Kerstin Papenfuss, Phd Mba | Director Pharma @ Deep Science Ventures |
View
|
|
| Gonzalo Fernández-miranda, Phd | Co-founder and CEO of Cureage | Barcelona, Catalonia, Spain |
View
|
Employees by Management Level
Executive
2 profiles
Director
1 profile
Individual contributor
1 profile
Compare Similar Companies to CureAge Therapeutics
Encoded Therapeutics Inc.
Biotechnology Research
Children's Tumor Foundation
Non-Profit Organizations
Deep Science Ventures
Venture Capital And Private Equity Principals
Antiverse
Biotechnology Research
Neobe Therapeutics
Biotechnology Research
Kasvu Therapeutics
Biotechnology Research
Plurify
Biotechnology Research
NOGA Therapeutics
Pharmaceutical Manufacturing
Panthura
Biotechnology Research
OligoTune
Biotechnology Research